Seroquel

Critical Warnings & Restrictions (Safety First)

Basic Seroquel Information

• INN (International Nonproprietary Name): Quetiapine
• Brand Names Available In Australia: Seroquel; Seroquel XR; generics (brand availability by pharmacy and supplier may vary)
• ATC Code: N05AH04
• Forms & Dosages: Immediate-release tablets (25 mg, 50 mg, 100 mg, 150 mg, 200 mg, 300 mg, 400 mg); Extended-release (XR) tablets (50 mg, 150 mg, 200 mg, 300 mg, 400 mg).
• Manufacturers In Australia: Not specified in the provided data; global supplier includes AstraZeneca and multiple generic manufacturers.
• Registration Status In Australia: Not specified in the provided data; quetiapine is registered in multiple jurisdictions for schizophrenia, bipolar disorder and adjunctive depression.
• OTC / Rx Classification: Prescription (Rx) only in all markets; not available over-the-counter.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who is at higher risk and what to watch for.

• Elderly (including dementia risk): Do not use for dementia-related psychosis due to increased mortality risk in elderly patients with dementia-related psychosis.
• Elderly — dosing caution: Start at lower doses (for example 25 mg/day) and titrate slowly because of greater sedation, orthostatic hypotension and sensitivity to side effects.
• Pregnancy: Requires specialist review before starting or stopping; weigh risks and benefits with an obstetric specialist and prescriber.
• Breastfeeding: Specialist review required to assess infant exposure and alternatives.
• Liver Impairment: Start at lower dose (for example 25 mg/day) and titrate cautiously because quetiapine is mainly metabolised by the liver.
• Cardiovascular Disease / Arrhythmias: Monitor blood pressure and ECG where indicated because orthostatic hypotension and tachycardia can occur.
• Seizure Disorders: Use with caution; seizures are a relative concern and monitoring is advised.
• Diabetes Or Metabolic Risk: Increased risk of weight gain and lipid/glucose changes; monitor metabolic parameters closely.
• Hematological Issues: History of leukopenia or neutropenia requires close monitoring of blood counts.
• Ophthalmic History: History of cataracts should prompt baseline visual checks where clinically appropriate.

Key Precautions Checklist

• Elderly: Start low (≈25 mg/day), slow titration, review for falls risk and cognitive change.
• Pregnancy / Breastfeeding: Specialist obstetric/paediatric review and documented informed consent.
• Liver Impairment: Reduced starting dose (≈25 mg/day), monitor LFTs.
• Cardiac Disease: Baseline ECG if risk factors present, monitor BP and pulse.
• Diabetes / Metabolic Syndrome: Baseline and ongoing metabolic monitoring.
• Seizure Risk: Review history and consider specialist input.

Baseline Tests Before Starting

• Blood pressure (including orthostatic readings where appropriate).
• Weight and body mass index.
• Fasting blood glucose.
• Lipid profile.
• Liver function tests.
• ECG where cardiac disease, arrhythmia risk, or concomitant QT‑prolonging drugs are present.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Can quetiapine affect my ability to work or drive?

Quetiapine commonly causes drowsiness and dizziness.

Many people feel sedated when they start or when the dose is increased.

Orthostatic hypotension from quetiapine increases the risk of falls, especially in shift workers and those doing manual tasks.

Until you know how quetiapine affects you, avoid driving or operating heavy machinery.

Employers have a duty of care under Australian workplace safety laws to assess fitness for safety‑critical tasks.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know how quetiapine affects you.

If you feel sedated, dizzy, lightheaded or less alert, do not drive or operate machinery.

This advice aligns with Australian road‑safety guidance that requires drivers to be free from impairment.

Discuss fitness to drive with your prescriber or pharmacist before returning to driving after starting or changing dose.

If an employer or insurer requests evidence, keep documentation of clinical advice from your GP or specialist.

If you must travel and feel uncertain, use alternative transport and avoid safety‑sensitive tasks until assessed.

Usage Basics

INN, Brand Names Available In Australia

What is sold under the name seroquel here and internationally.

Packaging is typically blister packs of 10, 30, 60 or 100 tablets depending on supplier and pharmacy.

Legal Classification (TGA‑Approved, PBS‑Listed)

What to expect at an Australian pharmacy when obtaining quetiapine.

Quetiapine is prescription‑only under the Therapeutic Goods Administration framework.

Many indications are subsidised through the Pharmaceutical Benefits Scheme where PBS criteria are met.

Prescribers must follow PBS authority rules for subsidised prescribing when required.

• Expect to present a valid prescription and Medicare details when claiming PBS subsidy where eligible.
• Some PBS indications require an authority number or special form from the prescriber.
• Pharmacies will check the prescription, confirm indication if needed, and provide counselling at supply.
• Repeats and supply quantities follow the prescriber’s directions and PBS rules where applicable.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Common adult dosing regimens by indication using product dosing guidance.

• Schizophrenia (adults): Start 25 mg twice daily; target 300–400 mg/day given in two to three divided doses; maximum 800 mg/day.
• Bipolar Mania (acute): Start 50 mg twice daily; increase to around 400 mg/day by Day 4; maximum 800 mg/day.
• Bipolar Depression (adults): Start 50 mg once daily at night; titrate to 300 mg at bedtime; maximum 300 mg/day.
• Adjunct In Major Depressive Disorder: 50 mg XR at bedtime, titrate up to 150–300 mg XR at bedtime; maximum 300 mg/day.
• Immediate Vs XR: Immediate-release is often split across the day for antipsychotic effect; XR formulations are commonly dosed once nightly.

Adjustments For Comorbidities

Age, liver function and renal status influence starting dose and titration.

• Children/Adolescents: Approved for schizophrenia from age ≥13 and bipolar mania from age ≥10; start at lower doses and titrate conservatively.
• Elderly: Start at lower dose (for example 25 mg/day) and increase slowly, monitoring sedation and falls risk.
• Hepatic Impairment: Reduce starting dose (for example 25 mg/day) and titrate with caution because quetiapine is mainly metabolised by the liver.
• Renal Impairment: No routine adjustment usually required, but use clinical caution and monitor response.

Q&A — “What If I Miss A Dose?”

If you remember soon after the missed dose, take it as soon as you remember.

If it is close to the time for your next dose, skip the missed dose and take the next dose at the scheduled time.

Never double up to make up a missed dose.

For XR tablets, do not crush, chew or split; take the tablet whole with water.

If you miss multiple doses or are unsure what to do, contact your prescriber or pharmacist for advice.

If withdrawal symptoms or worsening of psychiatric symptoms occur after missed doses, seek medical review promptly.

Missed Dose Checklist

• If remembered within a short time: take missed dose immediately.
• If near next dose: skip missed dose; resume regular schedule.
• Do not double dose.
• For XR: keep whole tablet; do not crush or chew.
• Contact prescriber or pharmacist after multiple missed doses or for guidance.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Common dietary interactions and practical advice.

• Alcohol: Alcohol plus quetiapine increases sedation and respiratory depression risk; avoid alcohol while stabilising on treatment.
• Caffeine: Caffeine may mask drowsiness but can increase anxiety or jitteriness in some people.
• Grapefruit: Grapefruit can interact with CYP pathways and may raise quetiapine levels; avoid grapefruit and grapefruit juice.
• Typical Australian Diet Considerations: High alcohol use in some groups means pharmacists should emphasise counselling on alcohol reduction while starting quetiapine.

Common Drug Conflicts

User Reports & Trends (Australian Patient Feedback)

What Australians commonly report in forums, review sites and pharmacy consultations.

• Sedation and improved sleep are commonly reported early effects.
• Daytime sleepiness and reduced energy are frequent complaints.
• Weight gain and increased appetite are commonly mentioned and a source of ongoing concern.
• Dry mouth, constipation and dizziness (including orthostatic symptoms) are often reported.
• Concerns about metabolic effects and the need for ongoing blood tests are common.
• Cost and PBS eligibility are frequent practical concerns, especially for long‑term users.

Note: Anonymised aggregate patient reports are useful for identifying trends but do not replace clinical guidance.

Report suspected adverse reactions to the TGA through official reporting channels.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Where to get seroquel and what to expect.

Major Australian pharmacy chains commonly stock quetiapine and generic versions, and they accept PBS scripts where applicable.

Price and availability vary between chains and between branded Seroquel and generic quetiapine.

What To Bring To The Pharmacy

• Valid prescription from an Australian prescriber.
• Medicare card for PBS claims where relevant.
• List of current medicines and known allergies.
• Any authority or PBS paperwork provided by the prescriber if required.

Online Pharmacies And Telehealth E-Prescriptions

How online ordering and telehealth prescriptions work in Australia.

• E‑prescriptions via telehealth are widely used and accepted by reputable Australian pharmacies.
• Ensure the online pharmacy is registered in Australia and dispenses using valid Australian prescriptions.
• Beware of overseas suppliers offering prescription medicines without a valid Australian prescription.
• Check for secure prescription handling, pharmacist counselling availability and privacy protections.

In our online pharmacy, seroquel is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

How quetiapine works in plain language.

Quetiapine is a second‑generation (atypical) antipsychotic.

It modulates neurotransmitter systems, particularly antagonism at serotonin 5‑HT2A and dopamine D2 receptors.

Affinity at histamine H1 and adrenergic α1 receptors contributes to sedation and orthostatic hypotension.

• D2 — Antipsychotic Efficacy: Dopamine D2 receptor antagonism reduces psychotic symptoms.
• 5‑HT2A — Mood/Psychosis Modulation: Serotonin 5‑HT2A antagonism may improve mood and reduce certain side effects compared with older agents.
• H1 — Sedation: Histamine blockade explains sedation and weight gain via increased appetite.
• α1 — Hypotension: Alpha‑1 blockade explains orthostatic hypotension and dizziness.

Clinical Terms

The pharmacology explains common adverse effects and monitoring needs.

Metabolism is hepatic, primarily via CYP pathways, so drug interactions are an important consideration.

Indications & Off‑Label Uses

Approved Indications By TGA

Primary licensed uses based on product approvals and common practice.

• Schizophrenia in adults.
• Bipolar disorder — acute mania and bipolar depression in adults, depending on formulation.
• Adjunctive therapy in major depressive disorder for certain patients when indicated.

Off‑Label Uses In Australian Clinical Practice

When clinicians sometimes prescribe outside product indications.

• Short‑term management of severe insomnia under careful clinical review (requires rationale and monitoring).
• Agitation or severe behavioural disturbance in selected settings with documented clinician justification.
• Anxiety spectrum conditions in complex cases where other options are unsuitable and with informed consent.

Off‑Label Use Checklist

• Document clear clinical rationale and expected benefit.
• Obtain informed consent and record discussion of risks and alternatives.
• Plan monitoring for sedation, metabolic effects and cardiac risk.
• Avoid use in dementia‑related psychosis due to increased mortality risk.

Key Clinical Findings (Evidence Summary 2022–2026)

What recent trials and real‑world data show about quetiapine’s benefits and harms.

Real‑world Australian data highlight adherence challenges related to sedation and cost burden for long‑term users.

Consult TGA, PBS and local guidelines for detailed trial references and prescribing algorithms.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

• Efficacy for the target symptom (psychosis, mania, depression).
• Metabolic burden and monitoring needs.
• Level of sedation and impact on daily function.
• Need for blood monitoring (e.g. clozapine requiring regular blood tests).
• Pregnancy and breastfeeding considerations.
• Cost and PBS availability for long‑term affordability.
• Patient preference and prior treatment response.

Common Questions (Australian Pharmacy FAQs)

Top questions pharmacists hear and short, practical answers.

• How long until it works?: Sedation can occur the same day; mood and psychotic benefits usually take days to weeks to become evident.
• Will it make me gain weight?: Weight gain is possible; monitor diet, weight and metabolic markers regularly.
• Pregnancy/breastfeeding?: Specialist review is required to assess risks and benefits before starting or stopping.
• Is it addictive?: Not classically addictive, but stopping abruptly can cause withdrawal symptoms and symptom recurrence.
• Interactions with alcohol?: Avoid alcohol; it increases sedation and impairment.
• What monitoring is needed?: Baseline and periodic weight, BP, fasting glucose, lipids and LFTs; ECG if cardiac risk is present.

Always escalate urgent concerns to emergency services or your GP if you experience severe side effects or sudden deterioration.

Price & Access Comparison Table

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Check PBS eligibility and bring Medicare or concession card where needed.
• Ask for generic options if cost is a concern.
• Consider mail‑order delivery if rural, but confirm delivery times and pharmacist counselling availability.
• Maintain regular GP and pharmacy contact for monitoring and repeats.

Registration & Regulation

TGA Approval

Regulatory points for prescribers and pharmacists in Australia.

• Quetiapine is listed as a prescription medicine and prescribers must supply appropriate indications on the prescription for PBS where relevant.
• Pharmacies must adhere to TGA labelling and storage requirements when dispensing medicines.
• Follow PBS criteria and authority procedures for subsidised prescriptions when required.

PBS Subsidy Details

PBS listings and authority requirements affect out‑of‑pocket cost.

Check the current PBS Schedule for exact subsidy and authority requirements before prescribing or dispensing.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Practical tips for keeping seroquel safe at home.

• Store at 15–30°C and protect from moisture and light.
• In hot or humid climates, keep medicine in original packaging and avoid bathrooms or car gloveboxes.
• Extended‑release tablets must not be crushed or chewed; keep them intact.
• Keep medicines out of reach of children and discard expired product safely.

Cold‑Chain Handling For Pharmacies

Pharmacy handling does not require refrigeration.

• No cold chain is required; ambient storage with temperature control is acceptable.
• Maintain stock rotation and ensure blister packs are intact before supply.
• Dispense XR products intact and counsel patients on administration and storage.

Guidelines For Proper Use (Counselling & Monitoring)

Australian Pharmacist Counselling Style

Key counselling points pharmacists should cover at initiation and review.

• Explain the indication and expected timeline for benefit and side effects.
• Discuss dosing schedule and differences between immediate‑release and XR formulations.
• Warn about sedation and fit‑to‑drive issues; advise on workplace safety.
• Explain orthostatic precautions to reduce falls risk.
• Discuss metabolic monitoring and necessary baseline tests.
• Review drug interactions including alcohol, CYP3A4 modifiers and other sedatives.
• Advise on missed doses and when to seek urgent care.
• Document counselling on the dispensing record for continuity of care.

Patient Advice From PBS And National Health Authorities

Recommended monitoring schedule and shared care planning.

• Baseline weight, blood pressure, fasting glucose and lipids, and liver function tests before or soon after initiation.
• Follow‑up review and repeat metabolic checks at around 3 months after initiation.
• Annual monitoring thereafter or more frequently if metabolic changes occur.
• Encourage shared care plans involving GP, psychiatrist and pharmacist for long‑term therapy.
• Report suspected adverse events to the TGA.

Monitoring Parameter / Recommended Timing:

• Weight: Baseline / 3 months / annual (more often if weight gain occurs).
• Blood Pressure: Baseline / early titration / periodic reviews.
• Fasting Glucose: Baseline / 3 months / annual.
• Lipids: Baseline / 3 months / annual.
• Liver Function Tests: Baseline and as clinically indicated.
• ECG: Baseline if cardiac risk factors present; repeat as needed.

Delivery Across Australia